Search - tctmd.com

Displaying 61 - 80 of 457

Sort: Relevancy | Date

Presentation THT 2025

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Presenter: Emily Rodriguez

February 11, 2025

Presentation THT 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT 2025

Left Bundle Branch Area Pacing: Implications for Long Term LV Function in Heart Failure

Presenter: Brett Atwater

February 11, 2025

Presentation THT 2025

Advances in Defibrillation for Patients With Heart Failure: Extravascular ICD and Beyond

Presenter: Sunil Kapur

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing

Presenter: Shunmuga Ponnusamy

February 11, 2025

Presentation THT 2025

Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?

Presenter: Andrea Russo

February 11, 2025

Presentation THT 2025

Left Atrial Appendage Closure: Should We Give Heart Failure Patients With AF the OPTION

Presenter: NULL

February 11, 2025

Presentation THT 2025

Emerging Questions in the Face of Multiple Effective Therapies

Presenter: Matthew Maurer

February 11, 2025

Presentation THT 2025

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Presenter: Mazen Hanna

February 11, 2025

Presentation THT 2025

Transcatheter Edge-to-Edge Repair: Buying Time and Function on the Way to Advanced Therapies?

Presenter: Ul Weena

February 11, 2025

Presentation THT 2025

Anti-Amyloid Therapy – Will Depleters Change the Game?

Presenter: Scott Solomon

February 11, 2025

Presentation THT 2025

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Presenter: Ahmad Masri

February 11, 2025

Presentation THT 2025

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Presenter: Giada Bianchi

February 11, 2025

Presentation THT 2025

Stabilizers for TTR Amyloidosis: Is One Better Than Another

Presenter: Jan Griffin

February 11, 2025

Presentation THT 2025

Differential Outcome of Hypotension vs. Hypoperfusion in SCAI Stage B Cardiogenic Shock: Insights From Houston Methodist Advanced Heart Failure Registry (HM-AHFR)

Presenter: Sumitabh Singh

February 11, 2025

Presentation THT 2025

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Presenter: Philipp Lurz

February 11, 2025

Presentation THT 2025

Preserving Access: Limiting the Use of Advanced Therapies

Presenter: Gerin Stevens

February 11, 2025

Presentation THT 2025

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Presenter: Nir Uriel

February 11, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

Presentation Controversies and Advances 2025

Changing ABO Blood Type During Ex Vivo Perfusion

Presenter: Fardad Esmailian

January 31, 2025

Advertisement

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Left Bundle Branch Area Pacing: Implications for Long Term LV Function in Heart Failure

Advances in Defibrillation for Patients With Heart Failure: Extravascular ICD and Beyond

Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing

Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?

Left Atrial Appendage Closure: Should We Give Heart Failure Patients With AF the OPTION

Emerging Questions in the Face of Multiple Effective Therapies

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Transcatheter Edge-to-Edge Repair: Buying Time and Function on the Way to Advanced Therapies?

Anti-Amyloid Therapy – Will Depleters Change the Game?

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Stabilizers for TTR Amyloidosis: Is One Better Than Another

Differential Outcome of Hypotension vs. Hypoperfusion in SCAI Stage B Cardiogenic Shock: Insights From Houston Methodist Advanced Heart Failure Registry (HM-AHFR)

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Preserving Access: Limiting the Use of Advanced Therapies

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

February 2025 Dispatch for the CV Team

Changing ABO Blood Type During Ex Vivo Perfusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content